Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Vet Parasitol ; 264: 47-51, 2018 Dec 15.
Article in English | MEDLINE | ID: mdl-30503091

ABSTRACT

The aim of this study was to evaluate the ability of melarsomine hydrochloride (Cymelarsan®) to cure horses suffering from a nervous form of dourine, a sexually-transmitted disease caused by Trypanosoma equiperdum. The recently described experimental model for assessing drug efficacy against horse trypanosomosis allowed us to obtain eight horses (Welsh pony mares) infected by T. equiperdum with parasites in their cerebrospinal fluid. The Cymelarsan® treatment evaluated consisted of the daily administration of 0.5 mg/kg of Cymelarsan® over 7 days. Two control horses remained untreated, three horses received the treatment 36 days p.i. and three horses received the treatment 16 days p.i. Following treatment, we observed parasite clearance in blood, stabilization of rectal temperature and a relative improvement in the mean packed cell volume levels for all treated horses. However, live parasites were later observed again in the CSF of all treated horses. Our results indicate the inability of Cymelarsan® to reach Trypanozoon located in the central nervous system of infected horses and thus discourage the use of Cymelarsan® to treat animals suffering from a nervous form of dourine.


Subject(s)
Arsenicals/therapeutic use , Cerebrospinal Fluid/parasitology , Dourine/cerebrospinal fluid , Dourine/drug therapy , Horse Diseases/cerebrospinal fluid , Horse Diseases/drug therapy , Animals , Arsenicals/standards , Female , Horse Diseases/parasitology , Horses/cerebrospinal fluid , Horses/parasitology , Treatment Failure , Trypanosoma/physiology
2.
Vet Parasitol ; 263: 27-33, 2018 Nov 15.
Article in English | MEDLINE | ID: mdl-30389021

ABSTRACT

Trypanosoma equiperdum, the causative agent of dourine, may affect the central nervous system, leading to neurological signs in infected horses. This location protects the parasite from most (if not all) existing chemotherapies. In this context, the OIE terrestrial code considers dourine as a non-treatable disease and imposes a stamping-out policy for affected animals before a country may achieve its dourine-free status. The use of practices as drastic as euthanasia remains controversial, but the lack of a suitable tool for studying a treatment's efficacy against dourine hampers the development of an alternative strategy for dourine infection management. The present study reports on the development of an experimental infection model for assessing drug efficacy against the nervous form of dourine. The model combines the infection of horses by Trypanosoma equiperdum and the search for trypanosomes in the cerebrospinal fluid (CSF) through an ultrasound-guided cervical sampling protocol. After a development phase involving four horses, we established an infection model that consists of inoculating 5 × 104T. equiperdum OVI parasites intravenously into adult Welsh mares (Equus caballus). To evaluate its efficacy, eight horses were infected according to this model. In all these animals, parasites were observed in the blood at 2 days post-inoculation (p.i.) and in CSF (12.5 ± 1.6 days p.i.) and seroconversion was detected (8.25 ± 0.5 days p.i.). All eight animals also developed fever (rectal temperature > 39 °C), low hematocrit (< 27%), and ventral edema (7.9 ± 2.0 days p.i.), together with other inconstant clinical signs such as edema of the vulva (six out of eight horses) or cutaneous plaques (three out of eight horses). This model provides a robust infection protocol that induces an acute trypanosome infection and that allows parasites to be detected in the CSF of infected horses within a period of time compatible with animal experimentation constraints. We conclude that this model constitutes a suitable tool for analyzing the efficacy of anti-Trypanosoma drugs and vaccines.


Subject(s)
Dourine/drug therapy , Horse Diseases/drug therapy , Horses/parasitology , Trypanosoma/drug effects , Anemia , Animals , Antibodies, Protozoan/blood , Disease Models, Animal , Dourine/cerebrospinal fluid , Dourine/parasitology , Drug Evaluation , Female , Horse Diseases/parasitology , Trypanosoma/isolation & purification
3.
Parasitology ; 145(7): 953-960, 2018 06.
Article in English | MEDLINE | ID: mdl-29166975

ABSTRACT

Trypanosoma equiperdum is a protozoan parasite responsible for causing Dourine, a debilitating neglected veterinary disease, found worldwide affecting equids. It is the only pathogenic trypanosome species that does not require an invertebrate vector for transmission, thus being passed from animal to animal via coitus. At present, there is no officially recognized form of chemotherapeutic treatment and therefore all confirmed (or suspected) cases of infected animals must be slaughtered immediately. For many global communities and farming populations, which rely heavily on their animals for their livelihood, such stringent regulations can seriously enhance the socio-economic problems attributing to poverty. Two reference drugs, together with 37 novel diamidine compounds were tested in vitro using a 72 h drug sensitivity assay to determine their efficacy against two axenically adapted T. equiperdum strains. Further in vivo investigations in mouse models of infection against 4 'true' T. equiperdum strains were performed using the 17 most active diamidines. Single bolus doses of 10 mg kg-1, given i.p. were administered to NMRI mice infected with one of the 4 T. equiperdum strains. The results obtained from this study show that experimentally T. equiperdum can indeed be effectively treated with chemotherapy using in vivo mouse models of infection.


Subject(s)
Dourine/drug therapy , Pentamidine/therapeutic use , Trypanosoma/drug effects , Animals , Disease Models, Animal , Drug Resistance , Female , Horse Diseases/drug therapy , Horse Diseases/parasitology , Horses , Mice , Neglected Diseases/parasitology , Neglected Diseases/veterinary
4.
Onderstepoort J Vet Res ; 43(2): 55-66, 1976 Jun.
Article in English | MEDLINE | ID: mdl-1018890

ABSTRACT

This paper is a record of observations on the transmission and clinical signs of dourine in naturally infected cases of known duration, and of temporal and quantitative aspects of the immune response in blood and cerebro-spinal fluid. Included in the record are observations on the presence of Trypanosoma equiperdum parasites in these body fluids and methods for their detection. There is evidence that the occurrence of nervous symptoms and lesions in infected horses is associated with the presence of Trypanosoma equiperdum parasites in cerebro-spinal fluid. The suitability of cerebro-spinal fluid as an environment for the parasite and its relationship with nervous manifestations of the disease are discussed. Observations support the previously reported lesions of peripheral polyneuritis and suggest a possible correltation between the consitstent position of the nervous lesions and the drainage of cerebro-spinal fluid containing the parasite. Chemotherapy with an experimental drug MSbE was used with varying results in 4 horses at different stages of infection.


Subject(s)
Horse Diseases , Trypanosomiasis/veterinary , Anemia/veterinary , Animals , Antimony/therapeutic use , Blood/parasitology , Cerebrospinal Fluid/parasitology , Dourine/drug therapy , Dourine/parasitology , Dourine/transmission , Edema/veterinary , Female , Horse Diseases/drug therapy , Horse Diseases/parasitology , Horse Diseases/transmission , Horses , Lymphadenitis/veterinary , Male , Trypanocidal Agents/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...